NASDAQ:ELTX

Elicio Therapeutics Stock Insider Trading

Healthcare > Biotechnology

Buy ELTX

*Your capital is at risk

$12.53

+1.04 (+9.05%)

At Close: Jun 03, 2026

Elicio Therapeutics Stock Insider Power

Based on the 90 latest insides trades, we have calculated the insider power to be positive at 100.00. In total, the insiders bought 25.22M and sold 6.98M ELTX shares in the last 90 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 90 transactions)	100.00
● Buy	25.22M shares
● Sell	6.98M shares
96% Buy Activity Negligible or No Correlation
No Significant Signals No statistically significant buy or sell signals detected in recent insider data.

Historical Insider Trades

Date	Type	Person	Role	Amount
Jun 28, 2024 Buy	Pre-Funded Warrants P-Purchase	Chudnovsky Yekaterina	Director	1 600 000 Value: $16.0K
Jun 28, 2024 Buy	Common Warrants P-Purchase	Chudnovsky Yekaterina	Director	1 600 000 Value: $8.00M
Jun 28, 2024 Buy	Pre-Funded Warrants P-Purchase	Venkatesan Jay Director	Director	50 000 Value: $500
Mar 19, 2024 Buy	Pre-Funded Common Stock Purchase Warrant P-Purchase	Chudnovsky Yekaterina	Director	1 032 702 Value: $10.3K
Mar 19, 2024 Buy	Pre-Funded Common Stock Purchase Warrant P-Purchase	Chudnovsky Yekaterina	Director	1 032 702 Value: $10.3K
Feb 01, 2024 Buy	Stock Option (right to buy) A-Award	Demuth Peter Chief Scientific Officer	Officer	342 Value: $2K
Feb 01, 2024 Buy	Stock Option (right to buy) A-Award	Piekos Brian Chief Financial Officer	C-Suite Officer	43 225 Value: $194.5K
Feb 01, 2024 Buy	Stock Option (right to buy) A-Award	Connelly Robert CEO, President And Director	CEO / President	225 137 Value: $1.01M
Feb 01, 2024 Buy	Stock Option (right to buy) A-Award	Haqq Christopher See Remarks	Officer	28 200 Value: $126.9K
Feb 01, 2024 Buy	Stock Option (right to buy) A-Award	Demuth Peter Chief Scientific Officer	Officer	29 800 Value: $134.1K
Feb 01, 2024 Buy	Stock Option (right to buy) A-Award	Demuth Peter Chief Scientific Officer	Officer	342 Value: $2K
Feb 01, 2024 Buy	Stock Option (right to buy) A-Award	Demuth Peter Chief Scientific Officer	Officer	29 800 Value: $134.1K
Feb 01, 2024 Buy	Stock Option (right to buy) A-Award	Haqq Christopher See Remarks	Officer	28 200 Value: $126.9K
Feb 01, 2024 Buy	Stock Option (right to buy) A-Award	Connelly Robert CEO, President And Director	CEO / President	225 137 Value: $1.01M
Feb 01, 2024 Buy	Stock Option (right to buy) A-Award	Piekos Brian Chief Financial Officer	C-Suite Officer	43 225 Value: $194.5K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks